Our in vitro findings demonstrate that ATM inhibition, particularly in combination with radiotherapy (RT), significantly reduces tumor cell survival and enhances cellular senescence, suggesting a potential strategy to increase the efficacy of RT in HNSCC. This evidence concerns the gene ATM and head and neck squamous cell carcinoma.